Powered by OpenAIRE graph
Found an issue? Give us feedback
ZENODOarrow_drop_down
ZENODO
Article . 2024
License: CC BY
Data sources: Datacite
ZENODO
Article . 2024
License: CC BY
Data sources: Datacite
versions View all 2 versions
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Review Article On The Topiramate Transdermal Patches In The Pharmacy

Authors: Vaibhav Kore*1, Anita Rahile2, Achal Lilhare3, Hrushikesh Sultane4, Bhumesh P. Lilhare5;

Review Article On The Topiramate Transdermal Patches In The Pharmacy

Abstract

Background: Transdermal drug delivery system (TDDS) was designed for the sustain release of content and for improving bioavilability of drug which improves patient compliance. There are various types of transdermal patches in which matrix dispersion type systems disperse the drug in the solvent along with the polymers and solvent is allowed to evaporate forming a homogeneous drug‑polymer matrix. To design and formulate TDDS of topiramate (TPM) and to evaluate their extended release in vitro and ex vivo was the main objective of present study. Materials and Methods: The Trandermal patches of topiramate (TPM) prepared by solvent casting method using a combination of ethylcellulose, polyvinylpyrolidone (PVP), eudragit L 100, calcium monophosphide (CAP), carbopol in various ratios using polyethylene glycol (PG) as a plasticizers and oleic acid, Tween 80 as a permeation enhancers were studied. Results: The physicochemical compatibility of the drug and the polymers was studied by Fourier transform infrared spectroscopy. The results obtained showed no physical‑chemical incompatibility between the drug and the polymers. The patches were further subjected to various physical evaluations along with the exvivo permeation studies using pig ear skin. Conclusions: On the basis of results obtained from the physical evaluation and ex vivo studies the patches containing the polymers, that is, Eudragit L 100 and polyvinylpyrrolidone, with oleic acid as the penetration enhancer were considered as the best formulations for the transdermal delivery of TPM.

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green
Upload OA version
Are you the author? Do you have the OA version of this publication?